Dag-uman, Sofia Marienela A.
HRN: 22-11-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/24/2022
10/31/2022
IVTT
2.1g
Q8
SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes